EQL Pharma AB (EQL.ST) Q2 2026 Earnings

8MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.11
0.04
0.19
0.34

Details

Expected EPS
0.1065931636
Actual EPS
0.3003989156
Surprise EPS
0.19
Surprise Percent
+181.82%

Description

EQL Pharma AB (EQL.ST) has reported earnings of 0.3003989156 per share for Q2 2026.

0 Comments

Share your thoughts